Gilberto Castaneda-Hernandez
Overview
Explore the profile of Gilberto Castaneda-Hernandez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
741
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Castaneda-Hernandez G, Espinoza M, Pino L, Rico-Restrepo M, Schiavetti B, Teran E, et al.
Adv Ther
. 2024 Oct;
41(12):4357-4368.
PMID: 39382823
Background: Biosimilars offer significant advantages for improving access to biologic treatments in Latin America. However, their uptake has been slow due to misconceptions, regulatory uncertainties, and inadequate pharmacovigilance. Objective: To...
2.
Saavedra-Fuentes N, Carmona-Montesinos E, Castaneda-Hernandez G, Campos I, Castillo-Salinas J, Castillo-Tapia J, et al.
Nutrients
. 2024 Sep;
16(17).
PMID: 39275246
Background: Current treatment for chronic kidney disease (CKD) focuses on improving manifestations and delaying progression. Nutritional approaches play a crucial role in CKD management, and various supplements have become available....
3.
Perez C, Luis-Islas J, Lopez A, Diaz X, Molina O, Arroyo B, et al.
PLoS One
. 2024 Apr;
19(4):e0300544.
PMID: 38656972
Obesity is a major global health epidemic that has adverse effects on both the people affected as well as the cost to society. Several anti-obesity drugs that target GLP-1 receptors...
4.
Sanchez-Trigueros M, Martinez-Vieyra I, Pineda-Pena E, Castaneda-Hernandez G, Perez-Cruz C, Cerecedo D, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2023 Dec;
397(6):4275-4285.
PMID: 38085291
Therapeutic effect of non-steroidal anti-inflammatory drugs (NSAIDs) has been related with gastrointestinal injury. Docosahexaenoic acid (DHA), an omega-3 polyunsaturated fatty acid (PUFA), can prevent gastric and small intestinal damage. Nonetheless,...
5.
Al-Naqqash M, Castaneda-Hernandez G, Chiang S, Ibnshamsah F, Reinert T, Rifkin R, et al.
Future Oncol
. 2023 Nov;
20(9):481-491.
PMID: 38010143
The aim of this plain language review article is to help you to understand biosimilar medicines (called biosimilars) by giving a summary of biologic medicines and biosimilars. It is based...
6.
Alnaqbi K, Bellanger A, Brill A, Castaneda-Hernandez G, Clopes Estela A, Delgado Sanchez O, et al.
Front Pharmacol
. 2023 Sep;
14:1188368.
PMID: 37693908
Although biosimilar uptake has increased (at a variable pace) in many countries, there have been recent concerns about the long-term sustainability of biosimilar markets. The aim of this manuscript is...
7.
Ortiz M, Carino-Cortes R, Castaneda-Hernandez G, Medina-Solis C
Can J Physiol Pharmacol
. 2022 Nov;
101(1):41-51.
PMID: 36318824
Pamabrom is a diuretic that is effective in treating premenstrual syndrome and primary dysmenorrhea. The aim of this study was to examine the effect of metformin and modulators of the...
8.
Barrios-Lopez V, Castelan-Martinez O, Arteaga-Rubio R, Hidalgo-Martinez M, Silva-Jivaja K, Castaneda-Hernandez G, et al.
Bol Med Hosp Infant Mex
. 2022 Jul;
79(3):180-186.
PMID: 35882027
Background: Due to many antineoplastic drugs' toxicity and narrow therapeutic window, medication errors are a health concern in pediatric oncology patients. This study aimed to identify and classify medication errors...
9.
Vargas-Neri J, Carleton B, Ross C, Medeiros M, Castaneda-Hernandez G, Clark P
Pharmacogenomics
. 2022 Feb;
23(5):291-301.
PMID: 35147047
The aim of this study was to evaluate the association between well-defined genetic risk variants in , and and anthracycline-induced cardiotoxicity in Mexican pediatric patients. We tested a cohort of...
10.
Rodriguez E, Rios A, Trujano-Ortiz L, Villegas A, Castaneda-Hernandez G, Fernandez C, et al.
J Inorg Biochem
. 2022 Jan;
229:111715.
PMID: 35074552
Amyloid aggregation of α-synuclein (AS) is one of the hallmarks of Parkinson's disease (PD). Copper ions specifically bind at the N-terminus of AS, accelerating protein aggregation. Its protein homolog β-synuclein...